TaurolockTMHep100

DEVICE2 trials

Sponsors

Palle Bekker Jeppesen, Rigshospitalet, Denmark

Conditions

Catheter Related Blood Stream InfectionsCatheter-related Bloodstream Infection (CRBSI) NosIntestinal Failure

Phase 4

Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.

Palle Bekker JeppesenCatheter-related Bloodstream Infection (CRBSI) Nos

Start: 2013-10-31End: 2016-12-31Target: 42Updated: 2016-04-06

Unknown Phase

Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections

CompletedNCT06660641

Rigshospitalet, DenmarkCatheter Related Blood Stream Infections, Intestinal Failure

Start: 2019-06-03End: 2022-02-28Updated: 2024-10-28

Related Papers

Taurolidine lock reduces recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: A randomized, placebo-controlled trial in a real-world clinical setting.

2025-06-032 citations

Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.

2017-08-0953 citations